Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function
Sponsor
West China Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT01825759
Collaborator
(none)
200
1
1
23
8.7
Study Details
Study Description
Brief Summary
The Impact of Compound danshen dropping pill for coronary heart disease (CHD) heart and artery structure and function in patients with hypertension
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Phase 4 |
Detailed Description
Compound danshen dropping pill for coronary heart disease (CHD) heart and artery structure and function in patients with hypertension.We can accorand the pwv ,IMT and MDA to assess the impact of heart and artery structure and function.
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
200 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Impact of Compound Danshen Dropping Pill for Coronary Heart Disease With Hypertension Patient Heart and Artery Structure and Function
Study Start Date
:
Jan 1, 2013
Anticipated Primary Completion Date
:
Dec 1, 2014
Anticipated Study Completion Date
:
Dec 1, 2014
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: danshen dripping pill danshen dripping pill 27mg ten pills by mouth every 8 hours for one year |
Drug: danshen dripping pill
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Pulse wave velocity [one year]
Secondary Outcome Measures
- ankle-brachial index [one year]
Other Outcome Measures
- intima-media thickness,methyl-di-aide-hyde [one year]
Eligibility Criteria
Criteria
Ages Eligible for Study:
35 Years
to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:coronary heart disease，primary hypertension， -
Exclusion Criteria:secondary hypertension，diabetes mellitus，chronic renal disease，cardiac insufficiency
-
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | West China Hospital | Chengdu | Sichuan | China |
Sponsors and Collaborators
- West China Hospital
Investigators
- Study Director: chen xi ping, master, organizer
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.Responsible Party:
Xiaoping Chen,
Compound danshen dropping pill for coronary heart disease with hypertension patient heart and artery structure and function,
West China Hospital
ClinicalTrials.gov Identifier:
NCT01825759
Other Study ID Numbers:
- West China Hospital
First Posted:
Apr 8, 2013
Last Update Posted:
Apr 8, 2013
Last Verified:
Mar 1, 2013
Additional relevant MeSH terms: